April 30, 2018 / 10:38 AM / 20 days ago

BRIEF-Baytacare Pharmaceutical Co Says Wang Shaoyan Removed As Chairman

April 30 (Reuters) - Baytacare Pharmaceutical Co Ltd :

* SUSPEND ROLES AND DUTIES OF WANG AS AN EXECUTIVE DIRECTOR WITH IMMEDIATE EFFECT

* SAYS REMOVES WANG SHAOYAN AS CHAIRMAN; FORMS SPECIAL INVESTIGATION COMMITTEE

* ANNOUNCES REMOVAL OF WANG SHAOYAN AS CHAIRMAN OF BOARD Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below